UR Vaccines to Prevent HIV Infection Clinical Research

The University of Rochester (UR) HIV Vaccine Trials Unit (HVTU) Clinical Research Site (CRS) is part of a large publicly funded multi-disciplinary collaboration called the HIV Vaccine Trials Network (HVTN).  The University of Rochester Medical Center was one of the first research sites in the United States to conduct HIV vaccine studies beginning in 1988.  The UR HVTU research is focused on developing an effective preventive HIV vaccine for those uninfected as well as help community members understand the general science of HIV/AIDS vaccines, research methods and clinical trial processes.

Think globally. Act locally. Join more than 30,000 people around the world in the search for a vaccine to stop the spread of HIV.